Pfizer Inc. news

   Watch this stock
Showing stories 11 - 20 of about 176   

Articles published

PFE 34.59 -0.68 (-1.93%)
price chart
Pfizer Inc. (PFE) Q1FY15 Earnings Preview: What You Need To Know
Pfizer Inc. (NYSE:PFE) is scheduled to release its first-quarter fiscal 2015 (1QFY15) earnings report before market opens on April 28.
Pfizer Inc. (PFE) Closes 0.25% Down on the Day for April 24  Equities.com
Pfizer Earnings Preview: 2 Ways to Trade PFE Stock  Investorplace.com
Pfizer Accused of Knowing Zoloft Posed Birth-Defect Risk
Pfizer Inc. researchers concluded last year that pregnant women taking Zoloft risked having babies with heart defects, according to evidence made public by a lawyer at the first trial of more than 1,000 lawsuits over the drug.
Pfizer Inc. Accused Of Withholding Information On Risks Associated With ...  Bidness ETC
Pharmalot�Pharmalittle�Good Morning: We're Catching up on Eisai, HepC ...  Wall Street Journal (blog)
Pfizer Inc. (PFE) Stock Update: Healthy Cancer Drug Pipeline Promises Strong ...
Pfizer Inc. (NYSE:PFE) has had quite an eventful month and the company's stock has gained as much as 1.87% in the past 30 days.
Pfizer's Once And Future Deals  Seeking Alpha
Pfizer Lifted to Hold at Vetr Inc. (PFE)  Dakota Financial News
Why Some Pfizer, Inc. Investors Are Kicking Themselves Now
Shareholders of Pfizer (NYSE: PFE ) are no doubt pleased with 2015 so far. The big pharma stock is up 12% year-to-date, easily beating the performance of the S&P 500 index.
Pfizer Stock Could Have Higher Prices In Store, But Will It Pull Back First?  Benzinga
Pfizer Inc. (PFE), Anthem Inc (ANTM), Aetna Inc (AET): Swedish Fund ...
Anders Hallberg and Carl Bennet's healthcare-focused fund, Healthinvest Partners AB, recently disclosed its equity holdings in a 13F filing with the Securities and Exchange Commission.
Pfizer Inc. (PFE) Wins FDA Breakthrough Therapy Designation For Lung Cancer ...
Pfizer Inc. (NYSE:PFE) has yet another victory to add to its long list of successes in the healthcare sector. Its lung cancer drug Xalkori has been granted "Breakthrough Therapy Designation" by the US Food and Drug Administration (FDA) for the ...
Pfizer Inc. (NYSE:PFE) Releases XALKORI Got Breakthrough Therapy ...  StreetWise Report
Active Movers - Pfizer, (NYSE:PFE), Intel Corporation, (NASDAQ:INTC), Under ...  wsnewspublishers
Pfizer Inc. (PFE) And Provectus Biopharmaceuticals Get US Patent For Cancer ...
Pfizer Inc. (NYSE:PFE) and Provectus Biopharmaceuticals Inc (NYSEMKT:PVCT) today received approval from the US Patent Office for a joint patent application filed by the two companies for their investigational cancer drug, PV-10.
Pfizer and Provectus Biopharmaceuticals Receive Patent Allowance for Use of ...  Yahoo Finance UK
Pfizer Inc. (PFE) Victorious In First Trial Over Zoloft Birth-Defect Claims
Pfizer Inc. (NYSE:PFE) ended the past week on a positive note as a court ruled that the company's antidepressant Zoloft did not cause birth defects in children born to mothers who took the pill during pregnancy.
Pfizer wins first US trial over Zoloft birth-defect risk  Reuters
Paul Weiss Scores for Pfizer in Zoloft Bellwether Trial  The Am Law Litigation Daily
Analyzing James Barrow's Top Holdings: Pfizer Inc.
Pfizer (PFE) is one of James Barrow (Trades, Portfolio)'s top ten holdings. As of the last quarter, his firm held 62.76 million shares of the company.
Pfizer and The Arthritis Society team up to support Canadians with arthritis
TORONTO, April 27, 2015 (GLOBE NEWSWIRE) -- The Arthritis Society and Pfizer Canada Inc. will join forces to support the education and empowerment of the 4.6 million Canadians living with arthritis.